These results demonstrate that MUC1-FA-[18F] SFB hybrid peptide conjugate may be useful as a dual receptor-targeting PET imaging probe for breast cancer detection and monitoring tumor response to the treatment, however, further evaluation is warranted. This evidence concerns the gene MUC1 and breast cancer.